Rezatapopt granted Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of TP53 Y220C positive ovarian cancerNew England Journal of Medicine published first-in-human ...
Initiated enrollment of Phase 1 Study of PRT12396, mutant-selective JAK2V617F inhibitor in patients with polycythemia vera ...
It’s not unusual for a Marvel movie to pull from the comics, or vice versa. Several characters, like the Guardians of the ...
Unexpected genetic benefit: A PTPN22 mutation tied to autoimmune diseases helped mice survive otherwise lethal coronavirus infection by enhancing natural killer cell function. Therapeutic potential: ...
New research from the University of Kansas shows a "risk gene" linked to higher odds of developing autoimmune diseases such ...
A 62-year-old man is poised to become the first person in Canada to be cured of HIV. Ten patients worldwide are considered ...
Her symptoms included feeling emotionless after having a baby and experiencing migraines for the first time in her life.
The hantavirus from the MV Hondius outbreak has been sequenced from samples taken from one of the infected individuals. The ...
A nanobody that stabilizes mutant CFTR from inside the cell, especially when combined with existing drugs, restores ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results